Although studies have shown that alcohol and cannabis misuse are related to impaired cognition in youth, previous studies were not designed to understand this relationship and differentiate whether cannabis use was causal or consequential to cognitive impairment. A new study by researchers at CHU Sainte-Justine and Université de Montréal, published in the American Journal of Psychiatry, shows that beyond the role of cognition in vulnerability to substance use, the concurrent and lasting effects of adolescent cannabis use can be observed on important cognitive functions and appear to be more pronounced than those observed for alcohol.
Beyond acute intoxicating effects, alcohol and cannabis misuse has been associated with impairments in learning, memory, attention and decision-making, as well as with lower academic performance. "While many studies have reported group differences in cognitive performance between young users and non-users, what had yet to be established was the causal and lasting effects of teen substance use on cognitive development," said co-author and PhD student at Université de Montréal, Jean-François G. Morin. Senior author and investigator Dr. Patricia Conrod, from the Department of Psychiatry at Université de Montréal, added that "very few studies are designed to look at this question from a developmental perspective. Our study is unique in that it followed a large sample of high school students from 7th to 10th grade using cognitive and substance-use measures. Using this big-data approach, we were able to model the complex nature of the relationship between these sets of variables."
To understand the relationship between alcohol, cannabis use and cognitive development among adolescents at all levels of consumption (abstinent, occasional consumer or high consumer), the research team followed a sample of 3,826 Canadian adolescents over a period of four years. Using a developmentally sensitive design, the authors investigated relationships between year-to-year changes in substance use and cognitive development across a number of cognitive domains, such as recall memory, perceptual reasoning, inhibition and working memory. Multi-level regression models were used to simultaneously test vulnerability and concurrent and lasting effects on each cognitive domain. The study found that vulnerability to cannabis and alcohol use in adolescence was associated with generally lower performance on all cognitive domains.
"However, further increases in cannabis use, but not alcohol consumption, showed additional concurrent and lagged effects on cognitive functions, such as perceptual reasoning, memory recall, working memory and inhibitory control," Conrod said. "Of particular concern was the finding that cannabis use was associated with lasting effects on a measure of inhibitory control, which is a risk factor for other addictive behaviours, and might explain why early onset cannabis use is a risk factor for other addictions." Morin added: "Some of these effects are even more pronounced when consumption begins earlier in adolescence."
In a context where policies and attitudes regarding substance use are being reconsidered, this research highlights the importance of protecting youth from the adverse effects of consumption through greater investment in drug-prevention programs.
"It will be important to conduct similar analyses with this cohort or similar cohorts as they transition to young adulthood, when alcohol and cannabis use become more severe," Conrod said. "This might be particularly relevant for alcohol effects: while this study did not detect effects of teen alcohol consumption on cognitive development, the neurotoxic effects may be observable in specific subgroups differentiated based on the level of consumption, gender or age." Morin added: "We also want to identify if these effects on brain development are related to other difficulties such as poor academic performance, neuroanatomical damage, and the risk of future addiction or mental health disorders."
About this study
The article entitled "A Population-Based Analysis of the Relationship between Substance Use and Adolescent Cognitive Development" was published in the American Journal of Psychiatry in October 2018. The first author is Jean-François G. Morin, B.A., a doctoral student under Patricia Conrod's supervision. Senior author is Patricia Conrod, Ph.D., Researcher and Director of the Venture laboratory at CHU Sainte-Justine, Full Professor in the Department of Psychiatry of Université de Montréal and holder of the Chair Dr Julien/Fondation Marcelle and Jean Coutu in Social and Community Pediatrics of Université de Montréal. This study was funded by the Canadian Institutes of Health Research, the Fonds de recherche du Québec - Santé, the Social Sciences and Humanities Research Council of Canada and the Canada Research Chair program. The authors report no financial relationships with commercial interests.
Authors: Jean-François G. Morin, BA, Mohammad H. Afzali, PhD, Josiane Bourque, MSc, Sherry H. Stewart, PhD, Jean R. Séguin, PhD, Maeve O'Leary-Barrett, PhD, Patricia J. Conrod, PhD
About the CHU Sainte-Justine Research Center
CHU Sainte-Justine Research Center is a leading mother-child research institution affiliated with Université de Montréal. It brings together more than 200 research investigators, including over 90 clinician-scientists, as well as 450 graduate and postgraduate students focused on finding innovative prevention means, faster and less invasive treatments, as well as personalized approaches to medicine. The Center is part of CHU Sainte-Justine, which is the largest mother-child center in Canada and second pediatric center in North America. More on research.chusj.org